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Abstract
Pseudomonas aeruginosa is able to form exopolysaccharide bi-
opolymer in the lungs of cystic fibrosis patients, increasing viscoe-
lasticity of sputum. In our studies, the viscosity of the biopolymer 
produced by P. aeruginosa 1604 was investigated in the presence 
of aspirin and sodium salicylate. The applied salicylic compounds 
in 0.3 % concentration decreased significantly the viscosity of 
the biopolymer during a five days period. The biopolymer of P. 
aeruginosa can harbour other virulence factors, such as pyocy-
anin. The applied salicylic compounds also decreased the pyocy-
anin production; however, according to our results P. aeruginosa 
1604 was able to produce pyocyanin after 72 h in the presence of 
0.1-0.2 % salicylic compounds. Consistent low pyocyanin produc-
tion was caused only in the presence of 0.3 % or higher concentra-
tion of these compounds.
Consequently, salycilic compounds decreased both the viscoe-
lasticity of the biopolymer and the concentration of pyocyanin pro-
duced by P. aeruginosa 1604.
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1 Introduction
P. aeruginosa is a wide spread opportunistic pathogen bacte-
rium, which presences in the lung and sputum of patient suffer-
ing from cystic fibrosis. Cystic fibrosis is a clinical syndrome 
characterized by chronic sinopulmonary infection, gastrointesti-
nal, nutritional, and other abnormalities. Chronic P. aeruginosa 
infection causes epithelial surface damage and airway plugging, 
which results decreased pulmonary function [1]. Moreover, P. 
aeruginosa plays role in superinfection of serious burn wounds 
and ulcer [2,3]. P. aeruginosa can form biofilms on biotic sur-
faces, such as in the lungs of cystic fibrosis patients triggering 
infections that are extremely difficult to eradicate [4].
P. aeruginosa growing in biofilms are less susceptible to bac-
teriophage, to amoebae, and to the chemically diverse biocides 
or antibiotics used to combat biofouling in industrial processes 
or in human therapy.
P. aeruginosa strains have different genotypes [5], as well 
as phenotypes. The mucoid bacterial cells, which attached in 
biofilm, can withstand host immune responses compare to the 
non-attached individual planktonic cells [6]. Firstly, patients 
are colonized by non-mucouid P. aeruginosa, however, as the 
disease progresses mucoid strains occur. In bacterial biofilm, 
there are bacterial cells enclosed in a polymeric matrix pro-
duced by the bacteria [7]. The mucoid exopolysaccharide ma-
terial of P. aeruginosa strains is mainly alginate, which is a 
heteropolymer of mannuronic and guluronic acid derivatives. 
This exopolysaccharide protects the bacterial cells due hinder-
ing antibiotics to reach cell surface and thus contributing to 
the antibiotic resistance of mucoid strains [8]. Furthermore, 
alginate produced by mucoid cells decreases the uptake and 
early antibacterial effect of aminoglycosides [9]. Alginate in-
creases the bacterial colonization within the respiratory tract 
by increasing their adherence to the respiratory epithelia [10]. 
Alginate also increases viscoelasticity of properties of sputum 
secreted by cystic fibrosis (CF) patient [11].
The increase stiffness of the sputum hinders the proper clear-
ance of fluid from the airway; therefore therapeutic methods 
are often directed to decreasing the viscoelastic parameters of 
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this fluid. CF sputa are typically highly viscous and elastic and 
are removed with difficulty by the ciliary and cough mecha-
nism. Therefore, decreasing stiffness of CF sputum is a major 
goal for treatment of this disease, and rheological characteriza-
tion of these materials can facilitate to modify viscoelasticity in 
the diseased state [12].
Furthermore P. aeruginosa caused serious problems include 
its ability to develop resistance to antibiotics, release a large scale 
of extracellular virulence factors, like elastase, alkaline protease, 
hemolysin, rhamnolipids and pyocyanin [13]. Pyocyanin alters 
Ca2+ homeostasis in human airway epithelial cells, including in-
hibition of the response to Ca2+ agonists, by this pyocyanin could 
interfere with critical host defense mechanisms contributing the 
symptoms in Pseudomonas associated lung disease [14]. Sali-
cylic acid and its derivatives are nonsteroidal anti-inflammatory 
drugs that inhibit growth and biofilm formation of P. aeruginosa 
and S. epidermidis and also downregulate some of the virulence 
factors in P. aeruginosa.  They have inhibitory effects both as a 
sole agent and in combination with antibiotics. It has been re-
ported that salicylic acid in vitro reduced the attachment of these 
bacteria to human corneal epithelial cells. Furthermore, salicylic 
acid has been shown to alleviate the virulence of P. aeruginosa 
on Arabidopsis thaliana and Caenorhabditis elegans [15].
Salicylic acid is known as a phenolic metabolite produced 
by plants. In plants salicylic acid plays an important role in the 
induction of plant defence responses against pathogen attack. 
Salycilic acid can reduce attachment and biofilm formation of 
P. aeruginosa on the roots of the Arabidopsis, however above 
a given concentration did not inhibit its growth. Furthermore, 
salicylic acid completely inhibited the aerobic biofilms, how-
ever it did not decrease the formation of anaerobic biofilm [16].
The affect of salicylic acid and its derivates on pyocyanin 
production of P. aeruginosa was generally monitored at low 
concentrations (0.1-1 mM) or in a specified concentration, 
but only for a short period (24 hours) [15,16]. Furthermore 
the formed biofilm was characterized based on its vitality and 
thickness [16,17,18]. However, these methods could not pro-
vide information about the long-term affect and the necessary 
inhibitory concentration of salicylic compounds and about the 
structure of exopolysaccharide biofilm. Therefore, the aim of 
present study is to investigate the effect of two salicylic com-
pounds, aspirin and sodium salicylate, on rheological proper-
ties of exopolysaccharide biopolymer and pyocyanin produc-
tion of the non-clinical origin Pseudomonas aeruginosa 1604 
in a long-term (120 hours) period.
2 Materials and Methods
2.1 Bacteria strain and culture conditions
P. aeruginosa 1604 strain isolated from reservoir water of a 
Hungarian oil well product was cultured in Bouillon medium 
(10 g peptone, 3 g Beef extract, 4 g Na2HPO4·2H2O, 3 g NaCl, 
pH adjusted to 7.2) for 24 hours at 37 °C in a shaker at 180 rpm.
2.2 Effect of salicylic acid/aspirin 
on biopolymer formation
The biopolymer was produced in modified Bouillon medium 
(10 g peptone, 3 g Beef extract, 2 g KH2PO4, 3 g NaCl, 8 g 
NH
4
NO3, 10 g sucrose, 1 g glucose, 5 % glycerol-rich product 
(30 % saponified palmitic acid and stearic acid, 62 % glycerol, 
1 % methanol, 7 % metallic salts)) at 37 °C, which was inocu-
lated with P. aeruginosa 1604 grown in Bouillon medium for 
24 hour. According to our previous experiences in this medium 
the biopolymer production of P. aeruginosa 1604 is significant-
ly enhanced compared to the original Bouillon medium. The 
final structure of biopolymer was formed after 5 days.
The biopolymer production was also investigated in the pres-
ence or absence of salicylic acid or aspirin. The concentrations 
of these compounds were in the range of 0.1 to 0.4 %.
2.3 Biopolymer characterization
The characterization of biofilm was studied by rheological 
method. The rheology of biopolymer was measured by us-
ing a Brookfield DV-II+ Viscometer. The biopolymer samples 
were measured after 5 days at 37 °C. The shear rate (s-1) vs. 
shear stress (Nm-2) curve was used in this study to character-
ize the flow ability of biopolymer. Since the characteristic of 
bacterial biopolymer is viscoelastic and the applied viscom-
eter is appropriate for viscous substances, data was calculated 
as the ratio of shear stress (Nm-2) to shear rate (s-1), which 
means the apparent viscosity [19]. Due to the inhomogene-
ous structure of the biopolymers (viscous-elastic gel or liquid 
depending on the concentration) the calculation of apparent 
viscosity was necessary.
2.4 Quantification of produced biopolymer
All of the biopolymer samples (25 ml) were precipitated 
with 1 % CaCl2 solution. During the process the systems were 
shacked for 4 hours, after that they were left stand overnight. 
The samples were filtrated and dried on 50 °C for one day and 
dry weight was determined. A blank measurement was also 
generated, that contained all the compounds of Bouillon-B me-
dium and P. aeruginosa 1604 cells at 1.8·107 CFUml-1 concen-
tration (in this sample biopolymer synthesis did not take place). 
The blank sample was also treated with 1 % CaCl2 solution in 
order to precipitate those macromolecules that able to interact 
with Ca2+ (besides biopolymer). The average of measured dry 
weight (g) values was referred to 100 ml biopolymer solution 
and data were added in w/v %.
2.5 Inhibition of pyocyanin production
The pyocyanin was produced in modified KingA medium 
(10 g whey powder, 1.4 g magnesium-chloride, 10 g potassi-
um-phosphate, 10 g sodium-citrate) at 37 °C, which was inocu-
lated with P. aeruginosa 1604 grown in Bouillon medium for 
24 hour. The amount of bacterial biomass was monitored by 
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Hach-Lange DR 5000 photometer at 600 nm. The pyocyanin 
production was investigated in the presence of salicylic acid or 
aspirin as well. The concentrations of these compounds were 
in the range of 0.1 to 0.4 %. The pyocyanin was produced in 
modified KingA medium also in these cases.
2.6 Quantification of pyocyanin
The pyocyanin production was investigated by a photo-
metric method after extraction according to Essar et al. [20]. 
A 5 ml sample of culture to maximize pyocyanin production 
was extracted with 3 ml of chloroform and re-extracted into 
1 ml of 0.2 N HCl to give a pink to deep red solution. Con-
centrations of pyocyanin in the culture supernatant were de-
termined based on the absorbance at 520 nm (Hach-Lange 
DR 5000 photometer) and expressed in μg ml-1 calculating 
with its extinction coefficient (2.46·103 M-1 cm-1, in 0.2 N 
HCl at 520 nm) [21].
3 Results
3.1 Rheological measurement
During the investigation of rheology properties of biopol-
ymer produced by P. aeruginosa 1604, it was found that the 
shear stress of the produced biopolymer was almost 45 Nm-2 
and the apparent viscosity was 1.97 Nsm-2 at 22 sec-1 shear rate. 
Based on the results, the investigated bacterium strain could 
produce high viscosity biopolymer during a five days period 
under appropriate conditions.
Figure 1 shows the changes of rheological features of the me-
dium in the presence of aspirin (A) or sodium salycilate (B) dur-
ing the biopolymer production compared to a control system. 
Based on the flow curves, the viscosity of the biopolymer 
decreased in case of growing concentration of salicylate com-
pounds. In the presence of 0.1 and 0.2 % aspirin the biopolymer 
had viscous property (0.64 and 0.69 Nsm-2 at 22 sec-1 shear 
rate), while at 0.3 and 0.4 % concentration the apparent viscos-
ity was 0.25 and 0.16 Nsm-2 at 22 sec-1 shear rate and the maxi-
mum shear stress decreased tenfold compared to the control. It 
is interesting, that 0.2 % aspirin reduced less the viscosity com-
pared to 0.1 %; however, the differences in the effect between 
these concentrations is not significant.
Sodium salicylate caused similar changes in the viscous 
properties of the biopolymer. In this case, significant decreas-
ing could be observed in the presence of 0.2 % sodium sali-
cylate (0.22 Nsm-2 at 22 sec-1). Furthermore, the growing con-
centration resulted in lower viscosity as it shown on the flow 
curves, apparent viscosity was 0.10 Nsm-2 at maximum shear 
rate and the maximum shear stress decreased tenfold at 0.4 % 
sodium salicylate 
Consequently, the investigated salicylic compounds could 
inhibit effectively the exopolysaccharide production of P. aer-
uginosa 1604; thereby these can be applicable for therapeutic 
targets, for example treatment of cystic fibrosis.
3.2 Quantification of produced biopolymer
Besides rheological properties, amount of the formed biofilm 
was measured as well. Therefore biopolymer samples produced 
during five days under appropriate conditions were coagulated 
by 1 % CaCl2 solution. The pellet of the precipitation was dried 
to constant weight.
As P. aeruginosa 1604 proved to be a mucoid strain, its 
biopolymer production was detected in modified Bouil-
lon medium in the presence and absence of salicylic com-
pounds after 5 days (Figure 2). Significant dry weight values 
(4.54 ± 0.59 %) were found in the absence of sodium salicylate 
and aspirin compared to the blank. The blank (line) shows the 
Fig. 1. Changes in the rheological features of biopolymer produced by P. 
aeruginosa 1604 in the presence of aspirin (A) and sodium salicylate (B) 
in different concentrations; ■ = control (0 %), ○ = 0.1 %, ∆ = 0.2 %, * = 0.3 %,  
◊ = 0.4 %.
Fig. 2. Changes in the amount of biopolymer produced by P. aeruginosa 
1604 in the presence of salicylic compounds; Line = blank, white column = dry 
weight of aspirin, grey column = dry weight of sodium salicylate.
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amount of macromolecules, which could be precipitated by CaCl2, 
however, they could not form viscoelastic biopolymer structure. 
The results also revealed that the applied aspirin or sodium 
salicylate at 0.1 % concentration were almost totally able to in-
hibit the synthesis of macromolecules responsible for alginate 
biopolymer formation. The amounts of the precipitated pellet 
were almost the same as the blank line 2.2 ± 0.12 %. Significant 
differences in the effect of aspirin and sodium salicylate were 
not detected according to the data. 
The results referred to the efficiency of the applied salicylic 
compounds in the inhibition of exopolysaccharide-type biopol-
ymer of Pseudomonas aeruginosa.
3.3 Inhibition of pyocyanin production
The other most important virulence factor of P. aeruginosa 
is pyocyanin beside exopolysaccharide production. Pyocyanin 
is an amphoter molecule, which is the basis of its detection. 
The pyocyanin production was investigated by a photometric 
method after extraction.
Before investigation of the inhibition, the production rate of 
pyocyanin and growth of biomass was monitored depending 
on time.
According to our results the growth of biomass reached the 
maximum (OD600 is 1.47) after 72 hours, while pyocyanin pro-
duction was in the exponential phase in this time. Therefore 
investigation of pyocyanin production in longer (120 hours) 
period is proved to be important, instead of the generally moni-
tored 24-48 hours [16].
It was found that pyocyanin, produced by P. aeruginosa 1604 
was significantly lower in the presence of aspirin or sodium sali-
cylate. Aspirin and salicylate decreased pyocyanin production 
by 58 % and 65 % after 120 hours as shown in the Figure 4. 
However, in the presence of 0.1 % aspirin or sodium salicylate, 
P. aeruginosa 1604 was still able to produce considerable 
amount (0.44 μgml-1) of pyocyanin after a 72 hours lag period. A 
constant suppression of pyocyanin production can be achieved 
using 0.3 % or higher concentration of these compounds.
According to our results, the applied salicylic compounds 
could inhibit not only biofilm forming of P. aeruginosa, but 
also they could decrease effectively the production of pyocy-
anin, which is one of the most important virulence factors.
4 Discussion
According to Prithiviraj et al. [16] some virulence factors of 
P. aeruginosa were inhibited by salicylic compounds [16], as 
well as P. aeruginosa 1604 originated from non-clinical condi-
tion. Altough the inhibition effect on biopolymer and pyocy-
anin synthesis was detectable in the case of both two salicylic 
compounds, aspirin and sodium salicylate had got different ef-
ficiency in these processes. In the case of inhibition of biopoly-
mer synthesis, sodium salicylate was more effective than aspi-
rin based on apparent viscosity, since at 0.2 % concentration 
and 22 sec-1 shear rate the apparent viscosity were 0.22 and 
0.69 Nsm-2 respectively the two compounds. However aspirin 
could inhibit more effectively the pyocyanin synthesis in 0.3 
and 0.4 % concentrations.
The physical properties of exopolysaccharide biopolymer 
produced by P. aeruginosa had essential importance in infec-
tion processes. Investigation of the thickness of created bio-
film [18] can not provide information about its structure and 
mechanical resistance. The rheological measurements clearly 
demonstrated that the investigated salicylic compounds in ap-
propriate concentrations could negatively influence the struc-
ture of synthesized biopolymer.
In previous studies the effect of salicylic compounds for 
P. aeruginosa was investigated at low concentrations for short 
Fig. 3. Growth and pyocyanin production of P. aeruginosa 1604; Light 
grey columns = average pyocyanin concentration, black squares = average 
OD600 value.
Fig. 4. Changes in the amount of pyocyanin in the presence of aspirin (A) 
and sodium salicylate (B) in different concentrations, black columns = control 
(0 %), white columns = 0.1 %, light grey columns = 0.2 %,  
grey columns =0.3 %, striped columns = 0.4 %.
79Inhibition of P. aeruginosa by salicylic compounds 2014 58 1
period [15,16] However our results demonstrated, that under 
appropriate grow conditions, the P. aeruginosa is able to sur-
vive in the presence of salicylic compounds for long-term. Al-
tough these salicylic compounds caused metabolic disorder in 
short-term, however P. aeruginosa 1604 could produce pyocy-
anin or biopolymer in a longer period. Furthermore for main-
tainence of the inhibition for longer period, significantly higher 
concentrations were necessary.
All these results referred to the possibility of clinical applica-
tions of aspirin and sodium salicylate in case of P. aeruginosa 
infections for example in CF, burn wounds and ulcers. Altough 
for the long-term inhibitions higher amount of applied salicylic 
compounds (0.3 and 0.4 %) are necessary, these concentrations 
generally applied in therapeutic practise in case of adults.
5. Conclusions
We successfully used sodium salicylate and aspirin in dif-
ferent concentrations to inhibit pyocyanin and biopolymer pro-
duction of Pseudomonas aeruginosa 1604. The amount of bi-
opolymer has decreased significantly after five days. Inhibition 
of pyocyanin production was investigated only in a 24h period 
previously [16]; in our study we have found that the long term 
inhibition can be achieved, but requires higher concentration 
of salicylic compounds: at 0.3 % concentration the inhibitory 
effect was evident for 120 hours.
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